Medicines derived from UK blood plasma distributed to NHS hospitals for ‘first time in a generation’
More than 250,000 litres of plasma from UK donors have been sent to human protein product manufacturer Octapharma to produce NHS medicines for the first time since a 1998 ban.
According to NHS Blood and Transplant, around 17,000 people in England need immunoglobulins to save or improve their lives each year
Shutterstock.com
The government has announced that medicines manufactured using plasma from UK donors are now being distributed to hospitals across the country.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
